Loading...
XSTO
BACTIb
Market cap62mUSD
Dec 05, Last price  
16.80SEK
1D
7.35%
1Q
-35.63%
Jan 2017
-0.59%
IPO
-47.83%
Name

Bactiguard Holding AB

Chart & Performance

D1W1MN
XSTO:BACTIb chart
P/E
P/S
2.42
EPS
Div Yield, %
Shrs. gr., 5y
1.02%
Rev. gr., 5y
5.67%
Revenues
244m
+19.46%
127,010,000117,516,0004,382,000129,005,000126,733,000109,047,000131,420,000118,736,000147,458,000150,097,000184,987,000172,315,000169,486,000223,560,000203,990,000243,680,000
Net income
-30m
L-78.45%
7,669,000-24,750,000-15,305,000-38,359,000-3,407,000-95,042,000-26,501,000-26,851,000-3,251,000-14,931,00016,256,000-38,389,000-58,773,000-52,877,000-138,382,000-29,815,000
CFO
25m
P
79,764,00056,714,000-2,680,000-40,916,000-45,070,000-35,743,000-20,791,000-12,411,0006,117,000-16,691,00053,982,000702,0007,256,0003,062,000-52,331,00024,989,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Bactiguard Holding AB (publ), a medical device company, engages in the development and supply of infection prevention solutions in Sweden and internationally. Its infection prevention solutions reduce the risk of healthcare associated infections and the use of antibiotics. The company's products portfolio of urinary catheters, endotracheal tubes, and central venous catheters reduces the risk of infections in the urinary tract, the respiratory tract, and the bloodstream. Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter and BIP Endotracheal Tube, which reduces the risk of biofilm formation and infection; BIP Endotracheal Tube Evac, a tube that combines the subglottic secretion drainage with coating to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that offers surveillance and infection prevention. The company's products also include Bactiguard Wound Care and Hydrocyn aqua advanced wound care, a wound wash, debridement, and irrigation solution for acute, chronic, and infected wounds; surgical sutures comprise non-absorbable, natural absorbable, synthetic absorbable, and specialty sutures; VigiMesh, a sterile, non-absorbable, and knitted polypropylene monofilament mesh material for tissue reinforcement used in hernia repair; and Hydrocyn aqua advanced disinfectant, a non-alcoholic disinfectant for skin and surfaces to kill bacteria, virus, and fungi. In addition, it offers ZNN Bactiguard, an orthopedic trauma implants with infection prevention technology; and Aniocyn, a wound and skin care products for dogs, cats, horses, and other pets. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Tullinge, Sweden.
IPO date
Jun 19, 2014
Employees
220
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT